EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management

Rahul Mittal, Karan Prasad, Joana R N Lemos iD, Giuliana Arevalo, Khemraj Hirani

International Journal of Molecular Sciences · 05.03.2025 · 26 (5) · 2320

DOI: 10.3390/ijms26052320 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.03.2025. Verfasst von Rahul Mittal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Diabetes, Gestational. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 357 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational diabetes mellitus (GDM) is characterized by an inadequate pancreatic β-cell response to pregnancy-induced insulin resistance, resulting in hyperglycemia. The pathophysiology involves reduced incretin hormone secretion and signaling, specifically decreased glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), impairing insulinotropic effects. Pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), impair insulin receptor substrate-1 (IRS-1) phosphorylation, disrupting insulin-mediated glucose uptake. β-cell dysfunction in GDM is associated with decreased pancreatic duodenal homeobox 1 (PDX1) expression, increased endoplasmic reticulum stress markers (CHOP, GRP78), and mitochondrial dysfunction leading to impaired ATP production and reduced glucose-stimulated insulin secretion. Excessive gestational weight gain exacerbates insulin resistance through hyperleptinemia, which downregulates insulin receptor expression via JAK/STAT signaling. Additionally, hypoadiponectinemia decreases AMP-activated protein kinase (AMPK) activation in skeletal muscle, impairing GLUT4 translocation. Placental hormones such as human placental lactogen (hPL) induce lipolysis, increasing circulating free fatty acids which activate protein kinase C, inhibiting insulin signaling. Placental 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) overactivity elevates cortisol levels, which activate glucocorticoid receptors to further reduce insulin sensitivity. GDM diagnostic thresholds (≥92 mg/dL fasting, ≥153 mg/dL post-load) are lower than type 2 diabetes to prevent fetal hyperinsulinemia and macrosomia. Management strategies focus on lifestyle modifications, including dietary carbohydrate restriction and exercise. Pharmacological interventions, such as insulin or metformin, aim to restore AMPK signaling and reduce hepatic glucose output. Emerging therapies, such as glucagon-like peptide-1 receptor (GLP-1R) agonists, show potential in improving glycemic control and reducing inflammation. A mechanistic understanding of GDM pathophysiology is essential for developing targeted therapeutic strategies to prevent both adverse pregnancy outcomes and the progression to overt diabetes in affected women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalHumansPregnancyFemaleInsulin ResistanceEndoplasmic Reticulum Chaperone BiPAnimalsSignal TransductionInsulin-Secreting Cells

Stichwörter der Autor:innen

dietary interventiongestational diabetes mellitusglucose intolerancehyperglycemiainsulin resistancematernal healthneonatal outcomespreeclampsia

Substanzen

HSPA5 protein, humanEndoplasmic Reticulum Chaperone BiP

Autor:innen und Institutionen

  • Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

ORCID-Profile: Joana R N Lemos

Zitieren

APA

Mittal, R., Prasad, K., Lemos, J. R. N., Arevalo, G., & Hirani, K. (2025). Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management. International Journal of Molecular Sciences, 26(5), 2320. https://doi.org/10.3390/ijms26052320

Vancouver

Mittal R, Prasad K, Lemos JRN, Arevalo G, Hirani K. Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management. International Journal of Molecular Sciences. 2025;26(5):2320. doi:10.3390/ijms26052320

BibTeX
@article{Mittal2025,
  author = {Mittal, Rahul and Prasad, Karan and Lemos, Joana R N and Arevalo, Giuliana and Hirani, Khemraj},
  title = {Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {2320},
  doi = {10.3390/ijms26052320}
}
Kostenlos starten →